SCHEMBL24080972

SCHEMBL24080972

CNC(=O)CC1(O)CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EPHX2 P34913 1/20 0.39
EPHX1 P07099 1/20 0.38
TSHR P16473 2/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
ATM Q13315 1/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CYP11B2 P19099 1/20 0.36
MMP2 P08253 1/20 0.36
MMP13 P45452 1/20 0.36
MMP14 P50281 1/20 0.36
ADAM17 P78536 1/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
GPR4 P46093 1/20 0.36
USP30 Q70CQ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25169698 0.84 USP2 (0.43) USP2SMN1; SMN2EPHX2EPHX1TSHR
SCHEMBL16553663 0.81 USP2 (0.44) USP2SMN1; SMN2EPHX2HPGDCYP11B2
SCHEMBL24012274 0.81 USP2 (0.44) USP2SMN1; SMN2EPHX2EPHX1HPGD
SCHEMBL9773945 0.80 USP2 (0.42) USP2SMN1; SMN2EPHX2HPGDCYP11B2
SCHEMBL3332689 0.80 USP2 (0.42) USP2SMN1; SMN2EPHX2EPHX1HPGD
SCHEMBL3031720 0.80 USP2 (0.46) USP2SMN1; SMN2EPHX2EPHX1TSHR
SCHEMBL3318268 0.80 CYP4F2 (0.45) USP2SMN1; SMN2EPHX2HPGDCYP11B2
SCHEMBL3314428 0.80 SMN1; SMN2 (0.41) USP2SMN1; SMN2EPHX2TSHRHPGD
SCHEMBL24752804 0.78 USP2 (0.45) USP2SMN1; SMN2EPHX2EPHX1TSHR
SCHEMBL31447849 0.78 USP2 (0.41) USP2SMN1; SMN2EPHX2HPGDHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166142-B Five-membered and six-membered heterocyclic compounds and application thereof as protein receptor kinase inhibitors 上海轶诺药业有限公司 2024-04-26 CN disclosed
EP-3919490-A1 FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITOR Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) 2021-12-08 EP disclosed
CN-113242857-A Preparation and application of imidazo aromatic ring compounds 上海轶诺药业有限公司 2021-08-10 CN disclosed
CN-113166142-A Five-membered and six-membered heterocyclic compounds and application thereof as protein receptor kinase inhibitors 上海轶诺药业有限公司 2021-07-23 CN disclosed
CN-111171019-A Five-membered and six-membered heterocyclic compounds and application thereof as protein receptor kinase inhibitors 上海轶诺药业有限公司 2020-05-19 CN disclosed
CN-111039946-A Preparation and application of imidazo aromatic ring compounds 上海轶诺药业有限公司 2020-04-21 CN disclosed